WORMZAP

This brand name is authorized in Nigeria.

Active ingredients

The drug WORMZAP contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0444	Suspension	WORMZAP SUSPENSION SUSP 100 mg/5 mL	WORMZAP SUSPENSION A11-0444 WORMZAP SUSPENSION Each 5ml contains: Albendazole BP 100mg, Methyl Paraben BP 10mg, Propyl Paraben BP 2.5mg, Sucrose BP 1950mg, Liquid Sorbitol BP 650mg, Xanthan Gum BP 15mg, Sodium Benzoate BP 10mg, Polysorbate 80 BP 5mg, Citric Acid (anhydrous) BP 3mg, Simeticone BP 1.25mg, Titanium Dioxide BP 100mg, Orange Flavour 0.02mg, Purified Water BP ..q.s…5ml Drugs ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS Drugs UNIQUE PHARMACEUTICALS LIMITED, FATAI ATERE WAY MATORI, MUSHIN LAGOS LAGOS 8097421000 UNIQUE PHARMACEUTICALS LIMITED, 11, FATAI ATERE WAY, MATORI, MUSHIN, LAGOS., Nigeria 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0444